290 related articles for article (PubMed ID: 31140596)
21. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
22. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
[TBL] [Abstract][Full Text] [Related]
23. Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.
Charalambous M; Bhatti SFM; Van Ham L; Platt S; Jeffery ND; Tipold A; Siedenburg J; Volk HA; Hasegawa D; Gallucci A; Gandini G; Musteata M; Ives E; Vanhaesebrouck AE
J Vet Intern Med; 2017 Jul; 31(4):1149-1158. PubMed ID: 28543780
[TBL] [Abstract][Full Text] [Related]
24. Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies.
Weiping L; Dong Z; Zhen H; Patten A; Dash A; Malhotra M
CNS Neurosci Ther; 2021 Mar; 27(3):330-340. PubMed ID: 33340263
[TBL] [Abstract][Full Text] [Related]
25. Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit.
Owusu KA; Dhakar MB; Bautista C; McKimmy D; Cotugno S; Sukumar N; Deng Y; Farooque P; Hirsch LJ; Maciel CB
Epilepsy Behav; 2019 Sep; 98(Pt A):161-167. PubMed ID: 31374472
[TBL] [Abstract][Full Text] [Related]
26. Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity.
Szaflarski JP; Sadek A; Greve B; Williams P; Varner JA; Moseley BD
Epilepsy Behav; 2020 Aug; 109():107127. PubMed ID: 32417382
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
[TBL] [Abstract][Full Text] [Related]
29. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
30. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
31. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular Versus Buccal Midazolam for Pediatric Seizures: A Randomized Double-Blinded Trial.
Alansari K; Barkat M; Mohamed AH; Al Jawala SA; Othman SA
Pediatr Neurol; 2020 Aug; 109():28-34. PubMed ID: 32387007
[TBL] [Abstract][Full Text] [Related]
34. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations.
de Haan GJ; van der Geest P; Doelman G; Bertram E; Edelbroek P
Epilepsia; 2010 Mar; 51(3):478-82. PubMed ID: 19817813
[TBL] [Abstract][Full Text] [Related]
35. A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension.
Yonker ME; McVige J; Zeitlin L; Visser H
Headache; 2022 Oct; 62(9):1207-1217. PubMed ID: 36286602
[TBL] [Abstract][Full Text] [Related]
36. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.
French JA; Krauss GL; Biton V; Squillacote D; Yang H; Laurenza A; Kumar D; Rogawski MA
Neurology; 2012 Aug; 79(6):589-96. PubMed ID: 22843280
[TBL] [Abstract][Full Text] [Related]
37. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.
Miller I; Scheffer IE; Gunning B; Sanchez-Carpintero R; Gil-Nagel A; Perry MS; Saneto RP; Checketts D; Dunayevich E; Knappertz V;
JAMA Neurol; 2020 May; 77(5):613-621. PubMed ID: 32119035
[TBL] [Abstract][Full Text] [Related]
38. Consistent safety and tolerability of Valtoco
Miller I; Wheless JW; Hogan RE; Dlugos D; Biton V; Cascino GD; Sperling MR; Liow K; Vazquez B; Segal EB; Tarquinio D; Mauney W; Desai J; Rabinowicz AL; Carrazana E;
Epilepsia Open; 2021 Sep; 6(3):504-512. PubMed ID: 34033266
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
40. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
